Bilistick Point-of-care System 2.0 Bilirubin Validation

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

June 16, 2024

Study Completion Date

September 9, 2024

Conditions
Neonatal ScreeningKernicterusNewborn JaundicePoint-of-Care Testing
Interventions
DIAGNOSTIC_TEST

Bilistick System 2.0 point-of-care testing device

The routine standard-of-care blood sample collection involves a 0.5 milliliter whole blood draw by the heel stick method for bilirubin assessments under current reference clinical methodology for total bilirubin. An additional 0.035 milliliter of whole blood will be collected for measurement in the point-of-care Bilistick System 2.0 (Bilistick point-of-care testing device). The resulting Bilistick System 2.0 data (i.e., total bilirubin) will be recorded, but will not be entered into the patients' electronic medical records or used for any diagnostic or medical decision purposes.

Trial Locations (1)

45429

Kettering Health Main Campus, Kettering

All Listed Sponsors
collaborator

Bilimetrix s.r.l.

OTHER

lead

Kettering Health Network

OTHER

NCT06058910 - Bilistick Point-of-care System 2.0 Bilirubin Validation | Biotech Hunter | Biotech Hunter